Suchergebnisse - "Venkatakrishnan, Karthik"

PubPharm (18)

1

Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors

enthalten in: Clinical pharmacology in drug development | 2023

von Zhou, X. | Richardson, D. | Dowlati, A. | +10

2

Population Pharmacokinetics of Ponatinib in Healthy Adult Volunteers and Patients With Hematologic Malignancies and Model-Informed Dose Selection for Pediatric Development

enthalten in: Journal of clinical pharmacology | 2022

von Hanley, M. | Diderichsen, P. | Narasimhan, N. | +3

3

Phase I study assessing the mass balance, pharmacokinetics, and excretion of [14C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2021

von Zhou, X. | Sedarati, F. | Faller, D. | +7

4

Phase I study assessing the mass balance, pharmacokinetics, and excretion of [14C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2020

von Zhou, X. | Sedarati, F. | Faller, D. | +7

5

Phase I study assessing the mass balance, pharmacokinetics, and excretion of [14C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2020

von Zhou, X. | Sedarati, F. | Faller, D. | +7

6

Phase I study assessing the mass balance, pharmacokinetics, and excretion of [14C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2020

von Zhou, X. | Sedarati, F. | Faller, D. | +7

7

Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors

enthalten in: Clinical pharmacology in drug development | 2020

von Patel, C. | Goel, S. | Patel, M. | +5

8

Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies

enthalten in: British journal of clinical pharmacology | 2019

von Faessel, H. | Mould, D. | Zhou, X. | +3

9

Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib in Adult Patients With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Dysfunction

enthalten in: Journal of clinical pharmacology | 2019

von Zhou, X. | Lockhart, A. | Fu, S. | +6

10

Effect of CYP3A inhibitors on the pharmacokinetics of pevonedistat in patients with advanced solid tumours

enthalten in: British journal of clinical pharmacology | 2019

von Faessel, H. | Nemunaitis, J. | Bauer, T. | +6